Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

On The Hunt For Vulnerable Plaque InfraReDx Improves Stenting Safety

This article was originally published in Start Up

Executive Summary

Whatever happened to vulnerable plaque? More than a decade ago, vulnerable plaque was a hot topic that was hoped would explain many incidents of sudden cardiac death in patients without other symptoms of coronary artery disease. While many experts believe the theory underlying this concept remains sound, proving its validity and then developing both diagnostic tools to identify what have been called "vulnerable patients" and then therapeutic devices to treat them has turned out to be a difficult and lengthy challenge that remains unsolved. InfraReDx Inc. remains active in this area, and according to CEO and founder James Muller, MD, is closing in on a solution. InfraReDx recently raised $21 million in its Series D financing round.
Advertisement

Related Content

Volcano Explodes in Therapy Guidance
Volcano Explodes in Therapy Guidance
InfraReDx: Saved by Angels (and a VC)
InfraReDx: Saved by Angels (and a VC)
Volcano's Second Act
Volcano Steps Up in Vulnerable Plaque By Buying Jomed's IVUS Business
Vulnerable Plaque: Medical Device's New Biological Frontier
Vulnerable Plaque Heats Up
The Unstable State of Plaque Detection

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037642

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel